Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

Original Article

J. Hammond, H. Leister-Tebbe, A. Gardner, P. Abreu, W. Bao, W. Wisemandle, M. Baniecki, V.M. Hendrick, B. Damle, A. Simón-Campos, R. Pypstra, and J.M. Rusnak

N Engl J Med 2022;386:1397-1408

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
04/13/2022
Course expires: 
04/14/2024

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation